Nasus Pharma Overview
Get informed when a big investor buys or sells
+ Follow-0.40
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for NSRX is -0.4. That is below the sector sector average of 9.98. Investors often review this figure alongside Nasus Pharma's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, NSRX currently prints -0.4 for PEG ratio, while the sector average sits near 9.98. That is roughly 104.0% below the sector mean. Large gaps often invite a closer look at Nasus Pharma's growth, margins, and balance sheet.
A PEG ratio of -0.4 for Nasus Pharma is not 'good' or 'bad' on its own. Compare it with the peer average (9.98) and with NSRX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting NSRX's PEG ratio (-0.4), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
